TSXV - Delayed Quote CAD

Entourage Health Corp. (ENTG.V)

Compare
0.0050
0.0000
(0.00%)
At close: January 27 at 1:29:53 PM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
41,464.0300
40,712.9820
40,892.0680
42,271.8340
29,433.9900
Cost of Revenue
37,232.1710
37,005.2840
60,783.0220
53,986.7560
53,639.5690
Gross Profit
4,231.8590
3,707.6980
-19,890.9540
-11,714.9220
-24,205.5790
Operating Expense
19,938.7740
25,085.6940
31,616.7290
30,023.7440
27,253.9760
Operating Income
-15,706.9150
-21,377.9960
-51,507.6830
-41,738.6660
-51,459.5550
Net Non Operating Interest Income Expense
-26,852.5460
-24,387.0380
-17,189.8010
-10,890.1520
-5,751.6150
Other Income Expense
394.4640
-402.9760
-54,448.9630
-26,306.3150
-32,395.9640
Pretax Income
-42,164.9970
-46,168.0100
-123,146.4470
-78,935.1330
-89,607.1340
Net Income Common Stockholders
-42,164.9970
-46,168.0100
-123,146.4470
-78,935.1330
-89,607.1340
Diluted NI Available to Com Stockholders
-42,164.9970
-46,168.0100
-123,146.4470
-78,935.1330
-89,607.1340
Basic EPS
-0.14
-0.15
-0.40
-0.32
-0.43
Diluted EPS
-0.14
-0.15
-0.40
-0.32
-0.43
Basic Average Shares
308,566.9880
307,848.7040
305,061.0310
249,012.5350
208,047.3220
Diluted Average Shares
308,566.9880
307,848.7040
305,061.0310
249,012.5350
208,047.3220
Rent Expense Supplemental
--
--
--
313.8100
240.8350
Total Expenses
57,170.9450
62,090.9780
92,399.7510
84,010.5000
80,893.5450
Net Income from Continuing & Discontinued Operation
-42,164.9970
-46,168.0100
-123,146.4470
-78,935.1330
-89,607.1340
Normalized Income
-41,012.6430
-44,197.0080
-68,637.7490
-46,669.0800
-53,230.8960
Interest Income
--
--
--
--
65.7600
Interest Expense
26,852.5460
24,387.0380
17,189.8010
10,774.4710
5,817.3750
Net Interest Income
-26,852.5460
-24,387.0380
-17,189.8010
-10,890.1520
-5,751.6150
EBIT
-15,312.4510
-21,780.9720
-105,956.6460
-68,160.6620
-83,789.7590
EBITDA
-14,674.4520
-21,396.8790
-100,104.4160
-61,407.6810
-76,787.0770
Reconciled Cost of Revenue
36,440.1730
36,624.1310
55,759.0610
49,970.7580
48,790.2450
Reconciled Depreciation
637.9990
384.0930
5,852.2300
6,752.9810
7,002.6820
Net Income from Continuing Operation Net Minority Interest
-42,164.9970
-46,168.0100
-123,146.4470
-78,935.1330
-89,607.1340
Total Unusual Items Excluding Goodwill
-1,152.3540
-1,971.0020
-54,508.6980
-32,266.0530
-36,376.2380
Total Unusual Items
-1,152.3540
-1,971.0020
-54,508.6980
-32,266.0530
-36,376.2380
Normalized EBITDA
-13,522.0980
-19,425.8770
-45,595.7180
-29,141.6280
-40,410.8390
12/31/2020 - 1/2/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DB.V Decibel Cannabis Company Inc.
0.0700
0.00%
 
KHRNF Khiron Life Sciences Corp.
0.0001
-98.75%
 
AVCN.TO Avicanna Inc.
0.2800
0.00%
 
AUSA.CN Australis Capital Inc.
0.0250
0.00%
 
526075.BO 526075.BO,0P0000BXCE,0
4.5000
0.00%
 
AX9.SG Akebia Therapeutics Inc
2.1600
-4.34%
 
R9U2.F Green Thumb Industries Inc.
6.84
+2.63%
 
6CQ.BE Cresco Labs Inc
0.8485
-3.91%
 
AX9.F Akebia Therapeutics, Inc.
2.2120
+0.45%
 
BON.SG Boiron SA
25.45
+0.99%